1328P Analysis of data from the AENEAS study assessing the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), aumolertinib, and virtual comparison with osimertinib

LaRose, M., Zhou, M., Lu, S., Wei, H., Bates, S. E., Schwartz, L., & Fojo, A. T. (2023). 1328P Analysis of data from the AENEAS study assessing the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), aumolertinib, and virtual comparison with osimertinib. Annals of Oncology, 34, S766–S767. https://doi.org/10.1016/j.annonc.2023.09.2361
Authors:
Mary LaRose
Ming Zhou
Shun Lü
Hongying Wei
Susan E. Bates
Lawrence H. Schwartz
Antonio Tito Fojo
Affiliated Authors:
Mary LaRose
Ming Zhou
Susan E. Bates
Antonio Tito Fojo
Columbia Affiliation:
Subjects:
Advancements in Lung Cancer Research (OpenAlex Topic)
Advancements in Colorectal Cancer Research (OpenAlex Topic)
HER2 Signaling in Breast Cancer Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1016/j.annonc.2023.09.2361
DOI:
10.1016/j.annonc.2023.09.2361
Journal:
Annals of Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: